MENLO PARK, Calif.--(BUSINESS WIRE)--CohBar, Inc. (OTCQX: CWBR and TSXV: COB.U), an innovative biotechnology company focused on developing mitochondria-based therapeutics (MBTs) to treat diseases associated with aging, today announced that it has engaged San Diego Torrey Hills Capital, Inc. (“Torrey Hills Capital”), a Rancho Santa Fe, California-based investor relations firm specializing in small and micro-cap companies, to provide market awareness and investor relations services to the Company, subject to TSX Venture Exchange acceptance. Torrey Hills Capital has been engaged to increase awareness about CohBar through its established relationships with investment professionals, investment advisors, and money managers focused on the microcap market space.
